Literature DB >> 9619492

The high cost of stroke to society, the family, and the patient.

R D Horner1.   

Abstract

Stroke is the third leading cause of mortality in the United States, after heart disease and cancer, and is a major cause of adult disability. Stroke-related neurologic deficits affect language, cognition, and motor function. They are often persistent, exerting a negative effect on the patient's quality of life. Besides affecting the patient, stroke also places a heavy emotional burden on the caregivers of patients with stroke. In the United States, the medical and nonmedical costs of caring for patients with stroke during the first year after their stroke are $30 billion/year, or approximately $50,000/patient. Many strokes are preventable, however, through judicious medical or surgical therapies. In addition, emerging thrombolytic and neuroprotective drugs, administered early after stroke onset, may minimize or eliminate some of the residual deficits associated with stroke. A massive educational effort is needed to raise public and professional awareness about stroke and emerging stroke therapies.

Entities:  

Mesh:

Year:  1998        PMID: 9619492

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Neurophysiological studies of chronic cerebral ischemia.

Authors:  N G Starosel'tseva
Journal:  Neurosci Behav Physiol       Date:  2009-07

2.  Major depressive disorder and stroke risks: a 9-year follow-up population-based, matched cohort study.

Authors:  Cheng-Ta Li; Ya-Mei Bai; Pei-Chi Tu; Ying-Chiao Lee; Yu-Lin Huang; Tzeng-Ji Chen; Wen-Han Chang; Tung-Ping Su
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 3.  Effects of Central Nervous System Drugs on Recovery After Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  See-Hwee Yeo; Zheng-Jie Ian Lim; Jia Mao; Wai-Ping Yau
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.